Literature DB >> 12583362

Should high hTg levels in the absence of iodine uptake be treated?

Peter Lind1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12583362     DOI： 10.1007/s00259-002-1003-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Should high hTg levels in the absence of iodine uptake be treated?

Authors:  K E Britton; R R Foley; S L Chew
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-04       Impact factor: 9.236

2.  Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment.

Authors:  Leonardo Pace; Michele Klain; Carmine Albanese; Barbara Salvatore; Giovanni Storto; Andrea Soricelli; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-05       Impact factor: 9.236

Review 3.  The role of nuclear medicine in differentiated thyroid cancer.

Authors:  Susanne Kohlfürst
Journal:  Wien Med Wochenschr       Date:  2012-07-20

4.  Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro.

Authors:  J T Deichen; C Schmidt; O Prante; S Maschauer; T Papadopoulos; T Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.